arrow
J

Jae-Hong Lee

university of ulsan
H指数:47
被引数:7,541

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction notice to “Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) study” [Sci. Total Environ. 668 (2019) 411–418]

撤稿通知:“暴露于环境细颗粒物与认知障碍患者的神经精神症状:来自韩国痴呆临床研究中心(CREDOS)研究的重复测量分析”[Sci. Total Environ. 668 (2019) 411–418]

2026-07-230
PRE
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

可溶性tau物种与阿尔茨海默病淀粉样斑块清除及tau病理的关系

2025-09-230
OAAI
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's disease

无症状常染色体显性遗传性阿尔茨海默病患者中突触血标志物β-突触核蛋白的早期增加

2025-04-100
OAAI
Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease
2024-10-080
PRE
Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease

运动与常染色体显性阿尔茨海默病生物标志物之间的纵向关联

2024-09-260
OA
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden

Α-突触核蛋白种子扩增测定法可检测常染色体显性遗传性阿尔茨海默氏病的Lewy体共病理,并取决于Lewy病理负担

2024-04-263
OA
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial
2024-03-011
PRE
Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease
2023-12-191
OAAI